Author:
Keitel-Anselmino Verena,Dröge Carola,Stindt Jan
Reference53 articles.
1. Baumann U, Sturm E, Lacaille F et al.: Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Clin Res Hepatol Gastroenterol 45 (2021) 101751.
2. Bull LN, van Eijk MJ, Pawlikowska L et al.: A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18 (1998) 219–224.
3. Chappell LC, Bell JL, Smith A et al. und Pitches study group: Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet 394 (2019) 849–860.
4. de Vree JM, Jacquemin E, Sturm E et al.: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95 (1998) 282–287.
5. de Vries E, Mazzetti M, Takkenberg B et al.: Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma. Liver Int 40 (2020) 3042–3050.